Skip to main content
. 2019 Dec 16;2019:6129748. doi: 10.1155/2019/6129748

Figure 1.

Figure 1

The ADAMTS-5 expression in human atheromatous plaques. (a) Western blot analysis of ADAMTS-5 in atheromatous plaques from normal donors and patients with coronary heart disease (CAD) (n = 6/group). ∗P < 0.05 versus donors. (b) The ADAMTS-5 expression in these two groups were measured by immunohistochemistry staining (n = 6/group, scale bar, 1000 μm for the left set of panels and 100 μm for the right panels). (c) The source of ADAMTS-5 was detected by double immunofluorescence staining (n = 6/group, scale bar, 100 μm).